Antonio Mannello

Title: Antonio Mannello: Innovator in Controlled-Release Granular Compositions

Introduction

Antonio Mannello is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of inflammatory pathologies of the intestinal tract. His innovative approach has led to the development of a unique patent that addresses specific medical needs.

Latest Patents

Antonio Mannello holds a patent for "Controlled-release granular compositions containing mesalazine and process for the manufacture thereof." This invention refers to controlled release granular compositions of mesalazine, which are designed to treat inflammatory conditions in the intestinal tract. The granular compositions consist of a central core made from an inert substrate, an intermediate layer containing mesalazine and one or more physiologically acceptable excipients, and a gastro-resistant coating. The patent also outlines a process for manufacturing these granular compositions, showcasing Mannello's expertise in pharmaceutical innovation.

Career Highlights

Antonio Mannello is currently associated with Sofar S.p.a., a company known for its commitment to developing innovative healthcare solutions. His work at Sofar S.p.a. has allowed him to focus on creating effective treatments that improve patient outcomes. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Antonio collaborates with Carla Labruzzo, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and advancing medical research.

Conclusion

Antonio Mannello's contributions to the field of controlled-release pharmaceutical compositions highlight his role as an innovator in healthcare. His patent for mesalazine compositions demonstrates his commitment to addressing medical challenges through scientific advancement.